New-onset Diabetes Mellitus after COVID-19 Infection in a Patient with Major Depression: A Case Report

10.4103/TPSY.TPSY_26_23

Ya-Ju Chang；Yung-Chieh Yen

台灣精神醫學

37卷3期（2023 / 09 / 01）

155 - 156

英文

1. Conn, DL(2001).Resolved: Low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis.Arthritis Rheum,45,462-467.
2. Gotzsche, PC,Johansen, HK(2004).Short-term low-dose corticosteroids versus placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.Cochrane Database Syst Rev,2005,CD000189.
3. Joseph, JJ,Golden, SH(2017).Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.Ann N Y Acad Sci,1391,20-34.
4. Kazakou, P,Lambadiari, V,Ikonomidis, I(2022).Diabetes and COVID-19; a bidirectional interplay.Front Endocrinol (Lausanne),13,780663.
5. Khunti, K,Del Prato, S,Mathieu, C(2021).COVID-19, hyperglycemia, and new-onset diabetes.Diabetes Care,44,2645-2655.
6. Metwally, AA,Mehta, P,Johnson, BS(2021).COVID-19-induced new-onset diabetes: trends and technologies.Diabetes,70,2733-2744.
7. Petersons, CJ,Mangelsdorf, BL,Jenkins, AB(2013).Effects of lowdose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease.Diabetes Care,36,2822-2829.
8. Reddy, PK,Kuchay, MS,Mehta, Y(2020).Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature.Diabetes Metab Syndr,14,1459-1462.
9. Stefanski, AL,Tomiak, C,Pleyer, U(2017).The diagnosis and treatment of Sjögren’s syndrome.Dtsch Arztebl Int,114,354-361.
10. Wrona, M,Skrypnik, D(2022).New-Onset diabetes mellitus, hypertension, dyslipidaemia as sequelae of COVID-19 infection-systematic review.Int J Environ Res Public Health,19,13280.